Title |
Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, May 2022
|
DOI | 10.2147/ndt.s358851 |
Pubmed ID | |
Authors |
Xin Meng, Ziling Zeng, Yunda Wang, Shuai Guo, Chunjuan Wang, Baojie Wang, Shougang Guo |
Mendeley readers
The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 8 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 25% |
Student > Ph. D. Student | 1 | 13% |
Other | 1 | 13% |
Professor > Associate Professor | 1 | 13% |
Student > Postgraduate | 1 | 13% |
Other | 0 | 0% |
Unknown | 2 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 63% |
Neuroscience | 1 | 13% |
Unknown | 2 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#4,899,152
of 25,630,321 outputs
Outputs from Neuropsychiatric Disease and Treatment
#689
of 3,140 outputs
Outputs of similar age
#104,365
of 447,191 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 29 outputs
Altmetric has tracked 25,630,321 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,191 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.